✦ LIBER ✦

Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients

✍ Scribed by Masakuni Noguchi

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 122 KB
Volume: 76
Category: Article
ISSN: 0022-4790
DOI: 10.1002/1096-9098(200102)76:2<144::aid-jso1028>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Morbidity following sentinel lymph node

Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

✍ Peter Schrenk; Roman Rieger; Andreas Shamiyeh; Wolfgang Wayand 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Axillary lymph node dissection for staging the axilla in breast carcinoma patients is associated with considerable morbidity, such as edema of the arm, pain, sensory disturbances, impairment of arm mobility, and shoulder stiffness. Sentinel lymph node biopsy electively removes the first lymph node,

The need to reexamine axillary lymph nod

The need to reexamine axillary lymph node dissection in invasive breast cancer

✍ Blake Cady 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

Pattern of lymphatic drainage to the sen

Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients

✍ Giuseppe Canavese; Marco Gipponi; Alessandra Catturich; Carmine Di Somma; Carlo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Initial experience in a community hospit

Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer

✍ Morgan, Alan; Howisey, Robert L.; Aldape, Hector C.; Patton, Richard G.; Rowboth 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Background and Objectives: To determine the sentinel node detection rate and the accuracy with which the sentinel node histology reflects that of the axilla in a series of patients with palpable invasive breast cancer. Methods: Forty-four patients with clinically node-negative palpable invasive T1 o